MALAT1 and Cirrhosis: Another four studies revealed that the serum TGFB2/TGFB2-OT1, lnc-SPARCL1-1:2, lncRNA RABGAP1L-DT-206, MALAT1, Neat1, and HULC expression were significantly higher in patients with advanced fibrosis/cirrhosis (F = 3–4) than in those without it (F = 0–2) [23,34,43,47].